188 related articles for article (PubMed ID: 28739498)
1. Increased expression of EZH2 in Merkel cell carcinoma is associated with disease progression and poorer prognosis.
Harms KL; Chubb H; Zhao L; Fullen DR; Bichakjian CK; Johnson TM; Carskadon S; Palanisamy N; Harms PW
Hum Pathol; 2017 Sep; 67():78-84. PubMed ID: 28739498
[TBL] [Abstract][Full Text] [Related]
2. Merkel cell carcinoma: Clinical outcome and prognostic factors in 351 patients.
van Veenendaal LM; van Akkooi ACJ; Verhoef C; Grünhagen DJ; Klop WMC; Valk GD; Tesselaar MET
J Surg Oncol; 2018 Jun; 117(8):1768-1775. PubMed ID: 29790179
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of ALK and EZH2 in Merkel cell carcinoma.
Veija T; Koljonen V; Bohling T; Kero M; Knuutila S; Sarhadi VK
BMC Cancer; 2017 Mar; 17(1):236. PubMed ID: 28359267
[TBL] [Abstract][Full Text] [Related]
4. Sentinel node status and immunosuppression: recurrence factors in localized Merkel cell carcinoma.
Jouary T; Kubica E; Dalle S; Pages C; Duval-Modeste AB; Guillot B; Mansard S; Saiag P; Aubin F; Bedane C; Dalac S; Dompmartin A; Granel-Brocard F; Lok C; Stoebner PE; Lacour JP; Leccia MT; Diallo A; Ezzedine K; Mateus C
Acta Derm Venereol; 2015 Sep; 95(7):835-40. PubMed ID: 25784178
[TBL] [Abstract][Full Text] [Related]
5. Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data.
Smith VA; Camp ER; Lentsch EJ
Laryngoscope; 2012 Jun; 122(6):1283-90. PubMed ID: 22522673
[TBL] [Abstract][Full Text] [Related]
6. INSM1 Is More Sensitive and Interpretable than Conventional Immunohistochemical Stains Used to Diagnose Merkel Cell Carcinoma.
Lilo MT; Chen Y; LeBlanc RE
Am J Surg Pathol; 2018 Nov; 42(11):1541-1548. PubMed ID: 30080705
[TBL] [Abstract][Full Text] [Related]
7. Merkel cell carcinoma: an Australian perspective and the importance of addressing the regional lymph nodes in clinically node-negative patients.
Howle JR; Hughes TM; Gebski V; Veness MJ
J Am Acad Dermatol; 2012 Jul; 67(1):33-40. PubMed ID: 21996296
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of "Nonsolid" Microscopic Metastasis in Merkel Cell Carcinoma Sentinel Lymph Nodes.
Erstine EM; Tetzlaff MT; Jia X; Aung PP; Prieto VG; Funchain P; Gastman BR; Billings SD; Ko JS
Am J Surg Pathol; 2019 Jul; 43(7):907-919. PubMed ID: 31094923
[TBL] [Abstract][Full Text] [Related]
9. ALK and EGFR expression by immunohistochemistry are associated with Merkel cell polyomavirus status in Merkel cell carcinoma.
Veija T; Kero M; Koljonen V; Böhling T
Histopathology; 2019 May; 74(6):829-835. PubMed ID: 30588655
[TBL] [Abstract][Full Text] [Related]
10. Tumor location is an independent prognostic factor in head and neck Merkel cell carcinoma.
Smith VA; MaDan OP; Lentsch EJ
Otolaryngol Head Neck Surg; 2012 Mar; 146(3):403-8. PubMed ID: 22166964
[TBL] [Abstract][Full Text] [Related]
11. Histological pattern of Merkel cell carcinoma sentinel lymph node metastasis improves stratification of Stage III patients.
Ko JS; Prieto VG; Elson PJ; Vilain RE; Pulitzer MP; Scolyer RA; Reynolds JP; Piliang MP; Ernstoff MS; Gastman BR; Billings SD
Mod Pathol; 2016 Feb; 29(2):122-30. PubMed ID: 26541273
[TBL] [Abstract][Full Text] [Related]
12. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.
Gángó A; Bátai B; Varga M; Kapczár D; Papp G; Marschalkó M; Kuroli E; Schneider T; Csomor J; Matolcsy A; Bödör C; Szepesi Á
Virchows Arch; 2018 Oct; 473(4):453-462. PubMed ID: 29858685
[TBL] [Abstract][Full Text] [Related]
13. Evaluating blood levels of neuron specific enolase, chromogranin A, and circulating tumor cells as Merkel cell carcinoma biomarkers.
Gaiser MR; Daily K; Hoffmann J; Brune M; Enk A; Brownell I
Oncotarget; 2015 Sep; 6(28):26472-82. PubMed ID: 26299616
[TBL] [Abstract][Full Text] [Related]
14. Merkel cell carcinoma: the prognostic implications of an occult primary in stage IIIB (nodal) disease.
Foote M; Veness M; Zarate D; Poulsen M
J Am Acad Dermatol; 2012 Sep; 67(3):395-9. PubMed ID: 22030017
[TBL] [Abstract][Full Text] [Related]
15. Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression.
Alford SH; Toy K; Merajver SD; Kleer CG
Breast Cancer Res Treat; 2012 Apr; 132(2):429-37. PubMed ID: 21614565
[TBL] [Abstract][Full Text] [Related]
16. High levels of antibodies against merkel cell polyomavirus identify a subset of patients with merkel cell carcinoma with better clinical outcome.
Touzé A; Le Bidre E; Laude H; Fleury MJ; Cazal R; Arnold F; Carlotti A; Maubec E; Aubin F; Avril MF; Rozenberg F; Tognon M; Maruani A; Guyetant S; Lorette G; Coursaget P
J Clin Oncol; 2011 Apr; 29(12):1612-9. PubMed ID: 21422439
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and predictive value of EZH2 expression and the tumor immune microenvironment in Merkel cell carcinoma.
Acikalin A; Bagir E; Paydas S
Pol J Pathol; 2021; 72(2):140-147. PubMed ID: 34706521
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Twist-1, E-cadherin and EZH2 in Prostate Cancer: An Immunohistochemical Study.
Abdelrahman AE; Arafa SA; Ahmed RA
Turk Patoloji Derg; 2017; 1(1):198-210. PubMed ID: 28832071
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance and prognostic role of EZH2 expression in non-small cell lung cancer.
Kim NY; Pyo JS
Pathol Res Pract; 2017 Jul; 213(7):778-782. PubMed ID: 28554757
[TBL] [Abstract][Full Text] [Related]
20. Merkel cell carcinomas infiltrated with CD33
Kervarrec T; Gaboriaud P; Berthon P; Zaragoza J; Schrama D; Houben R; Le Corre Y; Hainaut-Wierzbicka E; Aubin F; Bens G; Domenech J; Guyétant S; Touzé A; Samimi M
J Am Acad Dermatol; 2018 May; 78(5):973-982.e8. PubMed ID: 29273486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
